Edition:
India

People: Carmat SA (ALCAR.PA)

ALCAR.PA on Paris Stock Exchange

17.30EUR
6:27pm IST
Change (% chg)

€-0.06 (-0.35%)
Prev Close
€17.36
Open
€17.36
Day's High
€17.42
Day's Low
€17.28
Volume
4,698
Avg. Vol
8,923
52-wk High
€28.90
52-wk Low
€17.28

Jansen, Petrus 

Dr. Petrus (Piet) Jansen has been the Medical Director of Carmat SA since December 2009. Dr. Jansen has held manager positions at medical device companies focused on Circulatory Support since 1997. He was Chief Medical Officer at World Heart Corporation in Oakland CA, USA from 2004 to 2009. Dr. Jansen was Vice President, Clinical Programs at Orqis International GmbH from 2003 to 2004; Vice President, Clinical Affairs at Jarvik Heart Inc. (New York, USA) from 2001 to 2003. From 1997 to 2001, Dr. Jansen worked for the Novacor Division of Edwards Lifesciences LLC, formerly Baxter Corporation. Prior to joining the medical device industry, he worked multiple years in cardiac surgery clinics in Amsterdam, the Netherlands. Dr. Jansen has a Doctorate of Medicine Degree from Radboud University Nijmegen, a PhD in Pathophysiology of Extracorporeal Circulation from the Free University Amsterdam and a Post-doctorate degree in Clinical Epidemiology from the Universiteit van Amsterdam.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --